These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30357045)

  • 21. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.
    Szigeti G; Sedaghati E; Mahmoudabadi AZ; Naseri A; Kocsubé S; Vágvölgyi C; Varga J
    Mycoses; 2012 Jul; 55(4):333-8. PubMed ID: 21895787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
    Yenişehirli G; Bulut Y; Güven M; Günday E
    J Laryngol Otol; 2009 Sep; 123(9):978-81. PubMed ID: 19454132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study of 43 cases of fungal malignant external otitis.
    Halwani C; Mtibaa L; Hamdi ME; Baccouchi N; Benmhamed R; Jemli B; Akkari K
    Pan Afr Med J; 2022; 41():287. PubMed ID: 35855033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
    Nosratabadi M; Espahbodi A; Hedayati MT; Shokohi T; Badali H; Saeedi M; Moazeni M; Aghili SR; Javidnia J; Faeli L; Khojasteh S; Roohi B; Abbasi K; Abastabar M; Haghani I
    Mycopathologia; 2023 Apr; 188(1-2):119-127. PubMed ID: 36449121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents.
    Agarwal P; Devi LS
    J Clin Diagn Res; 2017 Jun; 11(6):DC14-DC18. PubMed ID: 28764159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Otomycosis in Damascus, Syria: Etiology and clinical features.
    Ismail MT; Al-Kafri A; Ismail M
    Curr Med Mycol; 2017 Sep; 3(3):27-30. PubMed ID: 29707671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent.
    Sabz G; Gharaghani M; Mirhendi H; Ahmadi B; Gatee MA; Sisakht MT; Hemati A; Mohammadi R; Taghavi J; Nouripour-Sisakht S
    J Med Microbiol; 2019 Apr; 68(4):585-590. PubMed ID: 30801244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular strategy for the direct detection and identification of the most common fungal community in cerumen specimens by multiplex PCR.
    Jabrodini A; Sohrabizdeh M; Aboutalebian S; Hashemi SB; Zomorodian K; Alirezaie A; Rasti Jahromi M; Shamsdin SN; Motamedi M
    J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37624031
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole.
    Chappe M; Vrignaud S; de Gentile L; Legrand G; Lagarce F; Le Govic Y
    J Mycol Med; 2018 Jun; 28(2):396-398. PubMed ID: 29673769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE MICROBIOLOGICAL STRUCTURE OF OTOMYCOSIS: SENSITIVITY PROFILE OF AGENTS TO ANTIFUNGAL DRUGS.
    Smiianov VA; Ivakhniuk TV; Plakhtiienko IO; Smiianov YV; Hornostaieva PO
    Pol Merkur Lekarski; 2023; 51(1):42-47. PubMed ID: 36960899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
    Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
    Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of otomycosis in Ibadan: a review of laboratory reports.
    Fayemiwo SA; Ogunleye VO; Adeosun AA; Bakare RA
    Afr J Med Med Sci; 2010 Dec; 39 Suppl():219-22. PubMed ID: 22420052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etiologic Agents of Otomycosis in the North-Western Area of Iran.
    Kazemi A; Majidinia M; Jaafari A; Ayatollahi Mousavi SA; Zarei Mahmoudabadi A; Alikhah H
    Jundishapur J Microbiol; 2015 Sep; 8(9):e21776. PubMed ID: 26495108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.